Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06513832 · ClinicalTrials.gov registry record · NA

Asthma Navigator Intervention to Improve Health Equity in Children

A NA study of Asthma in Children, sponsored by Emory University.

Recruiting
Registry status
NA
Development phase
75
Enrollment target
1
Study location

NCT06513832 is a NA study of Asthma in Children that is actively recruiting participants, run by Emory University. The registered enrollment target is 75 participants, below the 203-participant average among 44 other Asthma in Children trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06513832, a NA study of Asthma in Children, is actively recruiting participants, sponsored by Emory University.

RECRUITING
Registry status
NA
Development phase
75 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to improve health equity in children aged 5-16.9 years admitted to the PICU for asthma. The objectives are: * To identify the factors related to differential experiences of asthma self-management * To pilot the effectiveness of an individualized asthma navigator intervention at PICU discharge.

Conditions Studied

Interventions

  • BEHAVIORAL The asthma navigator

Study Locations (1)

Georgia

  • Children's Healthcare of Atlanta - Atlanta

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2025-01-17
Est. Completion 2026-08
Phase NA

Sponsor

Emory University

1,208 total trials

What the Registry Record Tells You About NCT06513832

The ClinicalTrials.gov registry entry for NCT06513832 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 203-participant average among 44 other Asthma in Children trials with a reported enrollment target (63% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Asthma in Children appearing as the primary indexed condition, and to 1 intervention - of which The asthma navigator is the first listed.

NCT06513832 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT06513832 about?

NCT06513832 is a clinical study titled "Asthma Navigator Intervention to Improve Health Equity in Children". The goal of this study is to improve health equity in children aged 5-16.9 years admitted to the PICU for asthma. The objectives are: * To identify the factors related to differential experiences of asthma self-management * To pilot the effectiveness of an individualized asthma navigator interventi...

What is the current status of trial NCT06513832?

This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2025-01-17. Estimated completion is 2026-08.

What conditions does trial NCT06513832 study?

This clinical trial studies the following conditions: Asthma in Children.

What interventions are being tested in trial NCT06513832?

The interventions under investigation include: The asthma navigator (BEHAVIORAL).

Who is sponsoring clinical trial NCT06513832?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06513832 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Asthma in Children

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.